Copertina

Bruton's tyrosine kinase inhibition suppresses pathological retinal angiogenesis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Siyue Chen, Yuming Liu, Yutian Zhang, Xu Guo, Tinghui Bai, Kai He, Yanfang Zhu, Yi Lei, Mei Du, Xiaohong Wang, Qiang Liu, Hua Yan
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Translational modelling to predict human pharmacokinetics and pharmacodynamics of a Bruton's tyrosine kinase‐targeted protein degrader BGB‐16673
di: Yue Wu, et al.
Pubblicazione: (2024)

Bruton tyrosine kinase (Btk) in neutrophils is indispensable for initiating and maintaining skin inflammation in a model of pemphigoid diseases
di: Henning Olbrich, et al.
Pubblicazione: (2026)

Pharmacology and safety of TAS5315, a Bruton tyrosine kinase inhibitor, in healthy volunteers: First‐in‐human, randomized, ascending‐dose studies
di: Yuji Kumagai, et al.
Pubblicazione: (2025)

Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real‐world study based on the United States Food and Drug Administration Adverse Event Reporting System database
di: Zeng‐Xiang Zhao, et al.
Pubblicazione: (2024)

Formulation breakthroughs driving broader tyrosine kinase use
di: Hans Lennernäs, et al.
Pubblicazione: (2026)

Targeting the tyrosine kinase Src in endothelium attenuates inflammation and atherogenesis induced by disturbed flow
di: Huanyu Ding, et al.
Pubblicazione: (2024)

Inhibition of proline‐rich tyrosine kinase 2 restores cardioprotection by remote ischaemic preconditioning in type 2 diabetes
di: Ralf Erkens, et al.
Pubblicazione: (2024)

Hand–foot skin reaction as a positive prognostic factor in vascular endothelial growth factor receptor‐tyrosine kinase inhibitor treatment
di: I‐Hsin Huang, et al.
Pubblicazione: (2026)

Therapeutic targeting of GSK‐3β activation by the tyrosine kinase RYK in pancreatic ductal adenocarcinoma with BJ‐2412, a novel sunitinib analogue
di: Kiran Yadav, et al.
Pubblicazione: (2026)

GL‐V9 inhibits Caspase‐11 activation‐induced pyroptosis by suppressing ALOX12‐mediated lipid peroxidation to alleviate sepsis
di: Li Chen, et al.
Pubblicazione: (2025)

α‐Linolenic acid suppresses Th17 cell differentiation to mitigate allergic rhinitis by binding to Lyn kinase in mast cells
di: Yuejin Wang, et al.
Pubblicazione: (2026)

Genetic deficiency or pharmacological inhibition of cGAS–STING signalling suppresses kidney inflammation and fibrosis
di: Baihai Jiao, et al.
Pubblicazione: (2025)

Development of a novel tyrosine kinase 2 inhibitor ARTS‐011 and its first‐in‐human single and multiple ascending dose Phase I study to evaluate the tolerability, safety, pharmacokinetic profile and food effects
di: Zhili Jin, et al.
Pubblicazione: (2026)

Pharmacological inhibition of the interleukin‐1 receptor‐associated kinase prevents angiotensin II‐induced cardiac remodelling in mice
di: Shreya Jaiswal, et al.
Pubblicazione: (2026)

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy
di: Zihan Qu, et al.
Pubblicazione: (2024)

Potential of natural flavonoids to target breast cancer angiogenesis (review)
di: Yuetong Wang, et al.
Pubblicazione: (2024)

Resveratrol, a novel inhibitor of fatty acid binding protein 5, inhibits cervical cancer metastasis by suppressing fatty acid transport into nucleus and downstream pathways
di: Xiao Chen, et al.
Pubblicazione: (2024)

E3 ubiquitin ligase Pellino1 suppresses acinar cell necroptosis and alleviates severe acute pancreatitis by promoting ubiquitin‐dependent receptor‐interacting protein kinase 3 (RIP3) degradation
di: Jiatong Chen, et al.
Pubblicazione: (2025)

Osthole targets doublecortin like kinase 1 (DCLK1/DCAMKL1) in macrophages to inhibit NF‐κB‐mediated inflammation and alleviate atherosclerosis
di: Sirui Shen, et al.
Pubblicazione: (2026)

TRPC6 suppresses liver fibrosis by inhibiting hepatic stellate cell activation via CaMK4‐CREB pathway
di: Shan Jiang, et al.
Pubblicazione: (2025)

A novel role for microtubule affinity‐regulating kinases in neuropathic pain
di: Yao‐Qin Shi, et al.
Pubblicazione: (2024)

Oroxylin A attenuates psoriasiform skin inflammation by direct targeting p62 (sequestosome 1) via suppressing M1 macrophage polarization
di: Yuxiang Ma, et al.
Pubblicazione: (2024)

Fatty acid binding protein 3 activates endothelial adhesion of circulating monocytes and impairs endothelial angiogenesis
di: Yen‐Wen Wu, et al.
Pubblicazione: (2025)

Sevoflurane acts as an antidepressant by suppression of GluN2D‐containing NMDA receptors on interneurons
di: Fei Guo, et al.
Pubblicazione: (2024)

Role of protein kinase A and A kinase anchoring proteins in buffering and compartmentation of cAMP signalling in human airway smooth muscle cells
di: Rinzhin T. Sherpa, et al.
Pubblicazione: (2024)

Carvedilol inhibits neuronal hyperexcitability caused by epilepsy‐associated KCNT1 mutations
di: Chang Di, et al.
Pubblicazione: (2024)

TREM2 activation suppresses central sensitisation by promoting autophagy in a chronic migraine model with recurrent nitroglycerin stimulation in mice
di: Suifa Hu, et al.
Pubblicazione: (2026)

Role of microtubule affinity‐regulating kinases in epilepsy: A novel therapeutic strategy
di: Min Xu, et al.
Pubblicazione: (2026)

Targeting FDX1 by trilobatin to inhibit cuproptosis in doxorubicin‐induced cardiotoxicity
di: Jiajia Wei, et al.
Pubblicazione: (2025)

SEW2871 attenuates myocyte necroptosis in heart failure through inhibition of oxidative stress and inflammatory cytokines
di: Hong‐Xia Guo, et al.
Pubblicazione: (2025)

Noncanonical function of sphingosine kinase 2 (SPHK2) sustains hepatic triglyceride homeostasis
di: Bingchuan Yuan, et al.
Pubblicazione: (2026)

Off‐target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
di: Francisco Alejandro Lagunas‐Rangel, et al.
Pubblicazione: (2024)

Bortezomib promotes neutrophil‐mediated bacterial clearance in sepsis by inhibiting plasmablast activation
di: Wang Jianyao, et al.
Pubblicazione: (2026)

ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents
di: Omar Soler‐Cedeño, et al.
Pubblicazione: (2025)

AMP‐activated protein kinase in the amygdala and hippocampus contributes to enhanced fear memory in diabetic mice
di: Aimi Yamagishi, et al.
Pubblicazione: (2024)

HMC ameliorates myocardial ischaemia–reperfusion injury through suppressing cuproptosis via the de‐ubiquitination and stabilization of ATP7A
di: Jia‐Bao Su, et al.
Pubblicazione: (2025)

Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
di: Aida Mohammadkhani, et al.
Pubblicazione: (2024)

Circular RNA regulatory role in pathological cardiac remodelling
di: Alessia Bibi, et al.
Pubblicazione: (2024)

Involvement of Piezo 1 in inhibition of shear‐induced platelet activation and arterial thrombosis by ginsenoside Rb1
di: Yilin Wang, et al.
Pubblicazione: (2025)

Cordycepin alleviates ischaemic brain injury by suppressing microglia‐induced neuroinflammation via regulating the Notch1 signalling pathway
di: Xing Li, et al.
Pubblicazione: (2026)